Some studies have shown that in NSCLC, smokers have a favorable trend for ICIs compared with non-smokers ( 53 – 55 ), which is consistent with our results.
← all excerpts
Efficacy of Atezolizumab for Advanced Non-Small Cell Lung Cancer Based on Clinical and Molecular Features: A Meta-Analysis.
1
—
—